| Targeting the DNA damage response pathway as a novel therapeutic strategy in colorectal cancer F Catalano, R Borea, S Puglisi, A Boutros, A Gandini, M Cremante, ... Cancers 14 (6), 1388, 2022 | 27 | 2022 |
| The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study SE Rebuzzi, A Signori, GL Banna, A Gandini, G Fornarini, A Damassi, ... Journal of Translational Medicine 20 (1), 435, 2022 | 12 | 2022 |
| The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives A Gandini, S Puglisi, C Pirrone, V Martelli, F Catalano, S Nardin, A Seeber, ... | 10 | 2023 |
| Clinical significance of germline pathogenic variants among 51 cancer predisposition genes in an unselected cohort of Italian pancreatic cancer patients A Puccini, M Ponzano, B Dalmasso, I Vanni, A Gandini, S Puglisi, R Borea, ... Cancers 14 (18), 4447, 2022 | 9 | 2022 |
| Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on … R Borea, D Favero, A Miceli, MI Donegani, S Raffa, A Gandini, ... Diagnostics 12 (3), 581, 2022 | 5 | 2022 |
| A novel immunotherapy prognostic score for patients with pretreated advanced urinary tract carcinoma from the subgroup analysis of the SAUL study. The urInary TrAct CArcinoma … G Fornarini, SE Rebuzzi, S Buti, P Rescigno, A Merseburger, U de Giorgi, ... medRxiv, 2022.08. 30.22279352, 2022 | 4 | 2022 |
| The role of the caregiver in older patients with advanced prostate cancer: Results from the ADHERE prospective study of the Meet-URO network EF Giunta, S De Padova, S Anpalakhan, U De Giorgi, M Maruzzo, ... Supportive Care in Cancer 31 (7), 425, 2023 | 2 | 2023 |
| Reliability of patient-reported toxicities during adjuvant chemotherapy M Cremante, A Pastorino, M Ponzano, M Grassi, V Martelli, A Puccini, ... European Journal of Cancer 182, 115-121, 2023 | 2 | 2023 |
| Durable response after immunotherapy discontinuation for delayed and severe immune-related adverse events: A case report G Pesola, V Murianni, SE Rebuzzi, GL Banna, L Cerbone, F Catalano, ... Immunotherapy 13 (17), 1379-1386, 2021 | 2 | 2021 |
| Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center A Puccini, S Nardin, L Trevisan, S Lastraioli, V Gismondi, I Ricciotti, ... European Journal of Cancer Prevention 33 (4), 355-362, 2024 | 1 | 2024 |
| Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer M Cremante, S Puglisi, A Gandini, A Guadagno, F Catalano, A Damassi, ... Journal of Oncology Pharmacy Practice 29 (7), 1748-1753, 2023 | 1 | 2023 |
| Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT A Gandini, M Bauckneht, L Sofia, L Tomasello, G Fornarini, E Zanardi Diagnostics 13 (17), 2733, 2023 | 1 | 2023 |
| Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report V Murianni, L Cerbone, P Rescigno, F Catalano, A Damassi, M Cremante, ... Immunotherapy 14 (18), 1419-1427, 2022 | 1 | 2022 |
| Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer A Gandini, V Martelli, L Belgioia, S Puglisi, M Cremante, V Murianni, ... ESMO Gastrointestinal Oncology 5, 100069, 2024 | | 2024 |
| Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study C Messina, M Catalano, G Roviello, A Gandini, M Maruzzo, U De Giorgi, ... Cancer Immunology, Immunotherapy 73 (9), 1-8, 2024 | | 2024 |
| Early-Onset colorectal Cancer: From the laboratory to the clinic A Gandini, J Taieb, H Blons, J Netter, P Laurent-Puig, C Gallois Cancer Treatment Reviews, 102821, 2024 | | 2024 |
| # 412 Pembrolizumab in metastatic cancer patients with microsatellite instability: subgroup analysis on endometrial cancer patients, results from a single center study S Puglisi, M Cremante, AL D’Amato, F Catalano, A Gandini, A Damassi, ... International Journal of Gynecologic Cancer 33 (Suppl 3), 2023 | | 2023 |
| Basal cell carcinoma of the prostate: a case report of a rare prostate cancer and review of the literature S Puglisi, M Cremante, P Rescigno, A Gandini, E Zanardi, G Fornarini, ... Acta Bio-medica: Atenei Parmensis 94 (S1), e2023232-e2023232, 2023 | | 2023 |
| The controversial abscopal effect: A single-center experience about the combination of stereotactic radiotherapy with pembrolizumab in patients with metastatic dMMR/MSI-H … A Gandini, V Martelli, L Belgioia, S Puglisi, M Cremante, V Murianni, ... Journal of Clinical Oncology 41 (16_suppl), 2608-2608, 2023 | | 2023 |
| Minerva Urology and Nephrology 2023 June; 75 (3): 308-18 G FORNARINI, SE REBUZZI, S BUTI, P RESCIGNO, A MERSEBURGER, ... Minerva 75, 2023 | | 2023 |
